Global Artesunate Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Artesunate Market Research Report 2024
Artesunate is a medication used to treat malaria and is part of the artemisinin-based combination therapy (ACT).
According to Mr Accuracy reports new survey, global Artesunate market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Artesunate market research.
MarketThe market for artesunate is driven by the high prevalence of malaria in tropical regions and the demand for effective antimalarial treatments. Artesunate plays a crucial role in malaria control and is widely used in malaria-endemic areas.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Artesunate market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
NHU
Guilin Pharma
KPC Pharmaceuticals
Nanjing Hicin Pharmaceutical
Fuyuan Pharmaceuticals
Kunming Baker Norton Pharmaceutical
Segment by Type
0.99
0.98
Tablets
Injection
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Artesunate report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports new survey, global Artesunate market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Artesunate market research.
MarketThe market for artesunate is driven by the high prevalence of malaria in tropical regions and the demand for effective antimalarial treatments. Artesunate plays a crucial role in malaria control and is widely used in malaria-endemic areas.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Artesunate market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
NHU
Guilin Pharma
KPC Pharmaceuticals
Nanjing Hicin Pharmaceutical
Fuyuan Pharmaceuticals
Kunming Baker Norton Pharmaceutical
Segment by Type
0.99
0.98
Segment by Application
Tablets
Injection
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Artesunate report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source